WHO embraces innovation in oncology
Interviewee/Contributor
Victoria English
Organisation
MedNous
Policy & Regulation
The precedents set by Zolgensma
Interviewee/Contributor
Victoria English
Organisation
MedNous
The use of patient registries for regulatory purposes
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
Brain health and disease in the digital era
Interviewee/Contributor
Victoria English
Organisation
MedNous
Building the antibiotic pipeline
Interviewee/Contributor
Wes Kim
Organisation
The PEW Charitable Trusts
What ATMP developers need to know about quality
Interviewee/Contributor
Houria Bachtarzi
Organisation
ERA Consulting (UK) Ltd
Single-arm studies set the pace of oncology
Interviewee/Contributor
Bruno Pagliara
Organisation
On-kòs Pharma Consulting
The shift towards value-based pricing for medicines
Interviewee/Contributor
Victoria English
Organisation
MedNous
NCI and industry: Moving innovations from the lab to patients
Interviewee/Contributor
Michael Salgaller and Michele Newton
Organisation
US National Cancer Institute
The productivity of oncology development continues
Interviewee/Contributor
Bruno Pagliara
Organisation
On-kòs Pharma Consulting